Real-world evidence for long-term safety and effectiveness of ipragliflozin in treatment-naïve versus non-naïve Japanese patients with type 2 diabetes mellitus: subgroup analysis of a 3-year post-marketing surveillance study (STELLA-LONG TERM).
Hiroshi MaegawaKazuyuki TobeIchiro NakamuraSatoshi UnoPublished in: Diabetology international (2021)
The online version contains supplementary material available at 10.1007/s13340-021-00501-w.